• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GE, Boston Children’s Partner to Develop App for Pediatric Brain Scans

by Jasmine Pennic 11/29/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

ge-bostonchildrens-brains-venture

Boston Children’s Hospital and GE Healthcare has formed a joint venture to develop and commercialize digital health tools to advance the diagnosis and treatment of specific childhood brain diseases. The first project of the collaboration involves developing an app that will improve diagnostic accuracy in pediatric brain scans by providing real-time contextual information at the time and place the radiologist needs it.

As part of the collaboration, both organizations will leverage GE Health Cloud and the clinical knowledge of radiologists at Boston Children’s, the two organizations are working to develop a decision support platform that is intended to help distinguish the large variability in brain MRI scans.  The new platform is expected to come pre-loaded with normative reference scans from young children of different ages for doctors worldwide to use as a benchmark when reading scans of pediatric patients.

Every day, tens of thousands of children undergo medical imaging. At Boston Children’s alone, nearly 1,000 imaging studies are performed each day. For general radiologists and pediatric imagers alike, the rapid changes in the body that occur as part of normal childhood development can pose challenges to accurately differentiate normal from abnormal.  Keeping up with the ever-growing litany of specific diagnoses can frustrate even the most experienced of radiologists.

“Pediatric brain scans of children under the age of four can be particularly tricky to read because the brain is rapidly developing during this period of childhood,” said Sanjay Prabhu, MBBS, pediatric neuroradiologist at Boston Children’s. “Since pediatric neuroradiologists are very scarce, we approached GE Healthcare to collaborate on the development of digital tools to help physicians of varying expertise read the scans.”

During infancy and childhood, complicated disorders, especially when affecting the brain symmetrically, may be misinterpreted as normal brain maturation. Conversely, normal expected developmental changes are sometimes misinterpreted as pathologic leading to unnecessary follow-on imaging or other diagnostic tests, which can be expensive, stressful and inconvenient to the child and family.

This first project with Boston Children’s is part of GE Healthcare’s overall goal of creating a deep learning library and plans to have hundreds of apps in the GE Health Cloud focused on a variety of diseases to transform healthcare by 2020, according to Charles Koontz, chief digital officer, GE Healthcare.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |